There has been a national clinical alert issued by the Department of Health and Social Care (NHS England) to highlight the current shortages in Attention Deficit Hyperactivity Disorder (ADHD) medications across the UK. The shortages are the result of increased demand and manufacturing issues.
As a result, the supply of ADHD medication is intermittent. This is likely to remain the case for the remainder of 2023.
Several ADHD medications have been affected: Equasym XL, Xaggitin XL, Concerta XL, Xenidate XL, Elvanse, Elvanse Adult, Guanfacine and Atomoxetine.
Please see the letter here from NHS England for full details.
It would be helpful if parents could alert us if their child is affected by this so that appropriate measures can be put in place to support your child.